Your browser doesn't support javascript.
loading
An Allosteric PRC2 Inhibitor Targeting EED Suppresses Tumor Progression by Modulating the Immune Response.
Dong, Hongping; Liu, Shaojun; Zhang, Xuejie; Chen, Sheng; Kang, Lijing; Chen, Yanni; Ma, Shichao; Fu, Xianlei; Liu, Yanchao; Zhang, Hailong; Zou, Bin.
Afiliação
  • Dong H; Shanghai Blueray Biopharma Co. Ltd., Shanghai, China. hongping.dong@blueraybiopharma.com bin.zou@blueraybiopharma.com.
  • Liu S; Shanghai Blueray Biopharma Co. Ltd., Shanghai, China.
  • Zhang X; Shanghai Blueray Biopharma Co. Ltd., Shanghai, China.
  • Chen S; Shanghai Blueray Biopharma Co. Ltd., Shanghai, China.
  • Kang L; Shanghai Blueray Biopharma Co. Ltd., Shanghai, China.
  • Chen Y; Shanghai Blueray Biopharma Co. Ltd., Shanghai, China.
  • Ma S; Shanghai Blueray Biopharma Co. Ltd., Shanghai, China.
  • Fu X; Shanghai Blueray Biopharma Co. Ltd., Shanghai, China.
  • Liu Y; Shanghai Blueray Biopharma Co. Ltd., Shanghai, China.
  • Zhang H; Shanghai Blueray Biopharma Co. Ltd., Shanghai, China.
  • Zou B; Shanghai Blueray Biopharma Co. Ltd., Shanghai, China. hongping.dong@blueraybiopharma.com bin.zou@blueraybiopharma.com.
Cancer Res ; 79(21): 5587-5596, 2019 Nov 01.
Article em En | MEDLINE | ID: mdl-31395608
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo / Complexo Repressor Polycomb 2 / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo / Complexo Repressor Polycomb 2 / Antineoplásicos Idioma: En Ano de publicação: 2019 Tipo de documento: Article